{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:29:01Z","timestamp":1793460541775,"version":"4.5.0"},"reference-count":42,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T00:00:00Z","timestamp":1240185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:p>Oral administration of hot\u2010water extract of Spirulina, cyanobacterium <jats:italic>Spirulina platensis<\/jats:italic>, leads to augmentation of NK cytotoxicity in humans. Here, we applied to syngeneic tumor\u2010implant mice (C57BL\/6 <jats:italic>versus<\/jats:italic> B16 melanoma) Spirulina to elucidate the mechanism of raising antitumor NK activation. A B16D8 subcell line barely expressed MHC class\u00a0I but about 50% expressed Rae\u20101, a ligand for NK activation receptor NKG2D. The Rae\u20101\u2010positive population of implant B16 melanoma was effectively eliminated in the tumor mass progressed in mice. This antitumor activity was induced in parallel with IFN\u2010\u03b3 and abolished in mice by treatment with asialoGM\u20101 but not CD8\u03b2 Ab, suggesting the effector is NK cell. NK cell activation occurred in the spleen of wild\u2010type mice medicated with Spirulina. This Spirulina\u2010mediated enhanced NK activation was abrogated in MyD88 \u2013\/\u2013 mice but not in TICAM\u20101 \u2013\/\u2013 mice. The NK activating properties of Spirulina depending on MyD88 were confirmed with <jats:italic>in vitro<\/jats:italic> bone marrow\u2010derived dendritic cells expressing TLR2\/4. In D16D8 tumor challenge studies, the antitumor effect of Spirulina was abolished in MyD88 \u2013\/\u2013 mice. Hence, orally administered Spirulina enhances tumoricidal NK activation through the MyD88 pathway. Spirulina exerted a synergistic antitumor activity with BCG\u2013cell wall skeleton, which is known to activate the MyD88 pathway via TLR2\/4 with no NK enhancing activity. Spirulina and BCG\u2013cell wall skeleton synergistically augmented IFN\u2010\u03b3 production and antitumor potential in the B16D8 <jats:italic>versus<\/jats:italic> C57BL\/6 system. We infer from these results that NK activation by Spirulina has some advantage in combinational use with BCG\u2013cell wall skeleton for developing adjuvant\u2010based antitumor immunotherapy. (<jats:italic>Cancer Sci<\/jats:italic> 2009)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2009.01188.x","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T08:11:46Z","timestamp":1240215106000},"page":"1494-1501","source":"Crossref","is-referenced-by-count":60,"title":["Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice"],"prefix":"10.1111","volume":"100","author":[{"given":"Yuusuke","family":"Akao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayo","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Hazeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Hazeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Seya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80412-2"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141126"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02200.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.12.003"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1201\/9781420052572.ch1"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3354\/meps022121"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000424464"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/np960017o"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.40.431"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2005.8.27"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(01)00166-7"},{"key":"e_1_2_6_13_2","first-page":"4369","article-title":"Innate immune therapy for cancer: application of BCG\u2010CWS and spirulina to patients with lung cancer","volume":"23","author":"Seya T","year":"2003","journal-title":"Anticancer Res"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.6883-6890.2000"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.8.4238-4249.2003"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-1518"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.6165"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605978104"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2760(97)00039-8"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/52.1.95"},{"key":"e_1_2_6_21_2","first-page":"1456","article-title":"Enhancement of metastatic capacity of fibroblast\u2013tumor cell interaction in mice","volume":"48","author":"Tanaka H","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a022194"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.5.1599"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm073"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2610"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2004.04226.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jjco.a023194"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","unstructured":"SeyaT MatsumotoM.The extrinsic RNA\u2010sensing pathway for adjuvant immunotherapy of cancer.Cancer Immunol Immunother2009 January 31 [Epub ahead of print].","DOI":"10.1007\/s00262-008-0652-9"},{"key":"e_1_2_6_29_2","unstructured":"SeyaT HazekiK InoueN MatsumotoM.Pattern\u2010recognition confers driving various cellular effectors on dendritic cells.Cancer Sci2009; in press."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2006.03.005"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2006.00450.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20010938"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.11.005"},{"key":"e_1_2_6_34_2","first-page":"195","volume-title":"Spirulina in human nutrition and health","author":"Seya T","year":"2007"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1860"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/01635589509514407"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006594318633"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0964-1955(95)00076-3"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1600457"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2005.8.27"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/35095564"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-008-3826-3"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07422-4"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2009.01188.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2009.01188.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:36:33Z","timestamp":1697423793000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2009.01188.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,10]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1349-7006.2009.01188.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01188.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,10]]}}}